Fields »
ABOUT
HELP
BLOG

974 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 20 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
A2MAlpha-2-macroglobulinCancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Expressed in all
ABCB1ATP-binding cassette, sub-family B (MDR/TAP), member 1Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Focal adhesion sites
Cytosol		Tissue enhanced
ABCC1ATP-binding cassette, sub-family C (CFTR/MRP), member 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Plasma membraneMixed
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
ABCC3ATP-binding cassette, sub-family C (CFTR/MRP), member 3Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneMixed
ABCC5ATP-binding cassette, sub-family C (CFTR/MRP), member 5Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleus
Plasma membrane
Cell Junctions		Expressed in all
ABCC6ATP-binding cassette, sub-family C (CFTR/MRP), member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
ABCG2ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)Cancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Plasma membrane		Tissue enhanced
ABL1ABL proto-oncogene 1, non-receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleoplasm
Nuclear bodies		Expressed in all
ABL2ABL proto-oncogene 2, non-receptor tyrosine kinaseCancer-related genes
Enzymes
Predicted intracellular proteins
RAS pathway related proteins
NucleoplasmMixed
ACAP1ArfGAP with coiled-coil, ankyrin repeat and PH domains 1Cancer-related genes
Plasma proteins
Predicted intracellular proteins
VesiclesTissue enhanced
ACLYATP citrate lyaseCancer-related genes
Citric acid cycle related proteins
Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cytosol		Expressed in all
ACPPAcid phosphatase, prostateCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ACVR1BActivin A receptor, type IBCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
CytosolExpressed in all
ACVR2AActivin A receptor, type IIACancer-related genes
Enzymes
Predicted membrane proteins
CytosolMixed
ACVR2BActivin A receptor, type IIBCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Nucleus
Nuclear bodies
Cytosol		Mixed
ADAM9ADAM metallopeptidase domain 9Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Endoplasmic reticulum
Vesicles		Expressed in all
ADAMTS1ADAM metallopeptidase with thrombospondin type 1 motif, 1Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolTissue enhanced
ADAMTS14ADAM metallopeptidase with thrombospondin type 1 motif, 14Cancer-related genes
Enzymes
Plasma proteins
Predicted secreted proteins
CytosolTissue enhanced
ADAMTS18ADAM metallopeptidase with thrombospondin type 1 motif, 18Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
ADAMTS20ADAM metallopeptidase with thrombospondin type 1 motif, 20Cancer-related genes
Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Not detected
ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif, 3Cancer-related genes
Enzymes
Predicted secreted proteins
Intermediate filamentsTissue enhanced
ADAMTS4ADAM metallopeptidase with thrombospondin type 1 motif, 4Cancer-related genes
Enzymes
Predicted intracellular proteins
Nuclear specklesTissue enhanced
ADAMTS5ADAM metallopeptidase with thrombospondin type 1 motif, 5Cancer-related genes
Enzymes
Predicted secreted proteins
NucleoplasmTissue enhanced
ADAMTS6ADAM metallopeptidase with thrombospondin type 1 motif, 6Cancer-related genes
Enzymes
Predicted secreted proteins
Tissue enhanced
ADAMTS8ADAM metallopeptidase with thrombospondin type 1 motif, 8Cancer-related genes
Enzymes
Plasma proteins
Predicted secreted proteins
Tissue enhanced
ADAMTS9ADAM metallopeptidase with thrombospondin type 1 motif, 9Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulum
Vesicles		Tissue enhanced
ADMAdrenomedullinCancer-related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
ADRA1BAdrenoceptor alpha 1BCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneTissue enhanced
AFPAlpha-fetoproteinCancer-related genes
Disease related genes
Plasma proteins
Predicted secreted proteins
CytosolTissue enhanced
AGERAdvanced glycosylation end product-specific receptorCancer-related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoli fibrillar center
Plasma membrane
Cell Junctions		Tissue enriched
AHRAryl hydrocarbon receptorCancer-related genes
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Cytosol		Mixed
AHSGAlpha-2-HS-glycoproteinCancer-related genes
Plasma proteins
Predicted secreted proteins
Golgi apparatusTissue enriched
AKAP12A kinase (PRKA) anchor protein 12Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol		Expressed in all
AKR1B1Aldo-keto reductase family 1, member B1 (aldose reductase)Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol		Tissue enriched
AKT1V-akt murine thymoma viral oncogene homolog 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleus
Microtubules		Expressed in all
AKT2V-akt murine thymoma viral oncogene homolog 2Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleus
Vesicles
Cytosol		Expressed in all
AKT3V-akt murine thymoma viral oncogene homolog 3Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
CytosolMixed
ALBAlbuminCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulum
Golgi apparatus		Tissue enriched
ALCAMActivated leukocyte cell adhesion moleculeCancer-related genes
CD markers
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ALDOAAldolase A, fructose-bisphosphateCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
CytosolTissue enriched
ALDOBAldolase B, fructose-bisphosphateCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Group enriched
ALDOCAldolase C, fructose-bisphosphateCancer-related genes
Candidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Vesicles
Cytosol		Tissue enriched
ALPLAlkaline phosphatase, liver/bone/kidneyCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolTissue enhanced
ALPPAlkaline phosphatase, placentalCancer-related genes
Enzymes
Plasma proteins
Predicted secreted proteins
Plasma membraneGroup enriched
ANGPT1Angiopoietin 1Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
ANGPT2Angiopoietin 2Cancer-related genes
Plasma proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol		Tissue enriched
ANXA11Annexin A11Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol		Expressed in all
ANXA2Annexin A2Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Transporters
Expressed in all

Page of 20 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.